Literature DB >> 39993

Elimination of prostacyclin (PGI2) and 6-oxo-PGF1 alpha in anaesthetized dogs.

J A Salmon, K M Mullane, G J Dusting, S Moncada, J R Vane.   

Abstract

The plasma concentration of 6-oxo-PGF1 alpha was measured by radioimmunoassay after constant rate infusion of 6-oxo-PGF1 alpha or prostacyclin (PGI2) into anaesthetized dogs. A steady-state plasma concentration was rapidly attained with both compounds. After termination of the infusions, the concentration of 6-oxo-PGF1 alpha declined according to a bi-exponential process. The steady-state plasma concentrations of 6-oxo-PGF1 alpha obtained after infusion of 6-oxo-PGF1 alpha and PGI2 were approximately 10 times higher than the corresponding steady-state level of PGF2 alpha measured after infusion of PGF2 alph into the same dogs. The data presented suggest that PGI2 and 6-oxo-PGF1 alpha are eliminated more slowly than PGF2 alpha, probably because they are not taken up and metabolized in the lungs as rapidly as PGF2 alpha.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 39993     DOI: 10.1111/j.2042-7158.1979.tb13577.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  2 in total

1.  The effects of nafazatrom in an acute occlusion-reperfusion model of canine myocardial injury.

Authors:  V B Fiedler; M Mardin; E Perzborn; R Grützmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

2.  Prostacyclin biosynthesis and reduced 5-HT uptake after complement-induced endothelial injury in the dog isolated lung.

Authors:  H Bult; J J Heiremans; A G Herman; C M Malcorps; F A Peeters
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.